Acquired Aplastic Anemia Companies

ID: MRFR/Pharma/3249-HCR

200 Pages

Vikita Thakur

Last Updated: February 16, 2025

Acquired aplastic anemia is a rare and serious blood disorder characterized by a deficiency of blood cells in the bone marrow. While there may not be specific companies exclusively focused on acquired aplastic anemia, various pharmaceutical and biotechnology companies may be involved in the development, manufacturing, and distribution of medications and therapies used in the treatment of bone marrow disorders and related conditions.

Acquired Aplastic Anemia Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)6.02%

2024 Market Size$ 1.85 Billion

2025 Market Size$ 1.96 Billion

2035 Market Size$ 3.52 Billion

Key Players

Amgen

Bristol-Myers Squibb

Novartis

Sanofi

Gilead Sciences

Celgene

Trends

Emergence of Targeted Therapies
Increased Awareness and Diagnosis
Technological Advancements in Treatment

Opportunities

Increased Awareness and Education
Advancements in Treatment Modalities
Regulatory Support for Innovative Therapies

Summary Table of Contents Segmentation Download PDF

Customize Report

Certified Researchers

Top Industry Leaders in the Acquired Aplastic Anemia Market

Latest Acquired Aplastic Anemia Companies Update

Novartis receives FDA approval for Cosentyx® (secukinumab) for treating moderate-to-severe AA in adults who have failed previous immunosuppressive therapy.

Apellis Pharmaceuticals introduces APL-2 (pegcetacoplan) for treating paroxysmal nocturnal hemoglobinuria (PNH), a condition often associated with AA, offering a potential new therapy option.

Regen Biopharma presents promising data from a Phase 2 clinical trial of REGN410, a novel immunosuppressive drug, demonstrating positive early results in AA patients

The Aplastic Anemia & MDS International Foundation (AA&MDSIF) partners with pharmaceutical companies and research institutions to fund clinical trials and accelerate development of new AA treatments.

The European Hematology Association (EHA) collaborates with researchers to develop standardized treatment guidelines and improve care for AA patients across Europe.

List of Acquired Aplastic Anemia Key Companies in the Market

Pfizer Inc. (U.S.)
Bayer AG (Germany)
Novo Nordisk AS (Dernmark)
Shire (Republic of Ireland)
SOBI (Sweden)
Octapharma (Switzerland)
CSL Limited (Australia)
Amgen Inc.
GlaxoSmithKline plc.
Bluebird bio.

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”